Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (781-790 of 874) with videos related to

Pageof 88
Sort By:
The New England Journal of Medicine|October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
Frontiers in Immunology|July 25, 2022
Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation CallingSara Bohnstedt Mørup, Lusine Nazaryan-Petersen, Migle Gabrielaite, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2013
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposiumDolores López-Terrada, Rita Alaggio, Maria T de Dávila, et al.
Journal of Neurology|December 16, 2024
Risk factors of long-term brain health outcomes after hospitalization for critical illnessC Peinkhofer, C S Grønkjær, L E Bang, et al.
Experimental Physiology|March 27, 2024
Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID-19: A prospective cohort study (the SECURe study)Anna Agnes Lytzen, Thora Wesenberg Helt, Jan Christensen, et al.
Frontiers in Endocrinology|September 18, 2023
Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional studyBibi Uhre Nielsen, Inger Hee Mabuza Mathiesen, Rikke Møller, et al.
The Journal of Infectious Diseases|August 27, 2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359Roy M Gulick, X Joan Hu, Susan A Fiscus, et al.
The Journal of Infectious Diseases|May 24, 2000
Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean womenT M Lampinen, S Kulasingam, J Min, et al.
Pageof 88

Showing results (781-790 of 874) with videos related to

Sort By:
Pageof 88
The New England Journal of Medicine|October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
Frontiers in Immunology|July 25, 2022
Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation CallingSara Bohnstedt Mørup, Lusine Nazaryan-Petersen, Migle Gabrielaite, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2013
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposiumDolores López-Terrada, Rita Alaggio, Maria T de Dávila, et al.
Journal of Neurology|December 16, 2024
Risk factors of long-term brain health outcomes after hospitalization for critical illnessC Peinkhofer, C S Grønkjær, L E Bang, et al.
Experimental Physiology|March 27, 2024
Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID-19: A prospective cohort study (the SECURe study)Anna Agnes Lytzen, Thora Wesenberg Helt, Jan Christensen, et al.
Frontiers in Endocrinology|September 18, 2023
Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional studyBibi Uhre Nielsen, Inger Hee Mabuza Mathiesen, Rikke Møller, et al.
The Journal of Infectious Diseases|August 27, 2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359Roy M Gulick, X Joan Hu, Susan A Fiscus, et al.
The Journal of Infectious Diseases|May 24, 2000
Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean womenT M Lampinen, S Kulasingam, J Min, et al.
Pageof 88